Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reauthorized Bill Could Offer Bigger Grants To More Small Med-Tech Firms

This article was originally published in The Gray Sheet

Executive Summary

The device industry and venture capital firms hope a House bill reauthorizing the Small Business Innovation and Research program will give more federal R&D funds to small firms regardless of their financial backing

You may also be interested in...



House Passes SBIR Reauthorization, Loosens Venture Capital Restrictions

A bill reauthorizing the Small Business Innovation Research (SBIR) program passed the House April 23. It would allow larger federal research and development grants to small companies and give the firms more flexibility in seeking funds from both federal agencies and venture capitalists

House Passes SBIR Reauthorization, Loosens Venture Capital Restrictions

A bill reauthorizing the Small Business Innovation Research (SBIR) program passed the House April 23. It would allow larger federal research and development grants to small companies and give the firms more flexibility in seeking funds from both federal agencies and venture capitalists

Small Business Investment Expansion Act May Get Senate Action Soon

The Senate Small Business and Entrepreneurship Committee may take up a bill this fall that would expand medical device companies' access to Small Business Innovation Research grants, according to AdvaMed

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025894

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel